EMEA-001523-PIP03-18-M02 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Immunology-Rheumatology-Transplantation
PIP number: P/0435/2022
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-001523-PIP04-19-M01 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Gastroentology-Hepatology
PIP number: P/0399/2022
Route(s) of administration: Intravenous useSubcutaneous use
Pharmaceutical form(s):
Solution for injection
Solution for injection in pre-filled syringe
Solution for injection in pre-filled pen
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-001523-PIP05-19-M01 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Gastroentology-Hepatology
PIP number: P/0065/2022
Route(s) of administration: Intravenous useSubcutaneous use
Pharmaceutical form(s):
Solution for injection (in pre-filled pen)
Solution for injection (in pre-filled syringe)
Solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Tremfya
guselkumab
Psoriasis
Date of authorisation:
Revision: 8
Last updated:
MedicineHumanAuthorised
Flynpovi
eflornithine
sulindac
Date of withdrawal:
Last updated:
MedicineHumanWithdrawn application
EMEA-001523-PIP02-14-M02 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Immunology-Rheumatology-Transplantation
PIP number: P/0129/2018
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman